Article

Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene.

Medical Research Council Group in Medical Genetics, The Montreal Children's Hospital Research Institute, Montreal, Canada.
Gene (Impact Factor: 2.08). 12/1999; 240(1):75-88. DOI: 10.1016/S0378-1119(99)00431-X
Source: PubMed

ABSTRACT Methionine synthase reductase (EC 2.1.1.135) is a flavoprotein essential for maintenance of methionine synthase in an active state. We characterized the human gene for methionine synthase reductase (MTRR). The gene is approximately 34kb and comprises 15 exons, varying in size from 43 to 1213bp, and 14 introns whose sizes vary from 108bp to 5kb. The positions of several junctions are conserved between the MTRR gene and the C. elegans ortholog, as well as with the rat cytochrome P450 reductase gene. A 1.3kb CpG island encompasses the 5'-flanking region and exon 1 and extends into intron 1. A short region including the transcription start site is sufficient to confer promoter activity, with a better outcome when accompanied by intron 1. The promoter region contains putative binding sites for Sp1, AP-1, AP-2 as well as CAAT motifs, but no consensus TATA box. Primer extension analysis revealed a single major transcription start site, located 137bp upstream of the previously reported initiator ATG. An alternative splicing event involving a portion of exon 1 predicts that translation can potentially be initiated at two different ATG codons. The gene was physically assigned to a narrow area between markers WI1755 and D5S1957.

0 Bookmarks
 · 
60 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ein 6 Monate alter blasser Säugling wird im sozialpädiatrischen Zentrum wegen Entwicklungsrückschritten vorgestellt. Bei der U4 war ein altersgerechter Entwicklungsstatus dokumentiert worden. Jetzt hat das Kind beim Traktionsversuch keine Kopfkontrolle mehr, freies Sitzen hat es verlernt. Es fällt ferner auf, dass das voll gestillte Kind in den letzten 3 Wochen kein Gewicht zugenommen hat. Da die Mutter eine Blutentnahme zunächst ablehnt, wird unter der Verdachtsdiagnose Vitamin-B12-Mangel Spontanurin untersucht, der eine erhöhte Ausscheidung von Methylmalonsäure zeigt. In der wenig später doch gewonnen Blutprobe ist der Serum-Vitamin-B12-Spiegel deutlich erniedrigt. Im Blutbild finden sich Hämoglobin 5,7 g/dl, MCV 127 fl, Retikulozyten 50 Promille, Thrombozyten 100.000/μl und Leukozyten 3800/μl. Die erweiterte Anamnese erbringt, dass sich die Mutter als Veganerin seit mehreren Jahren und auch während der Schwangerschaft und Stillperiode ohne tierisches Eiweiß ernährt. Bei normalen Blutbildwerten hat sie eine deutlich erniedrigte Vitamin-B12 Serumkonzentration.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A revision about the role of hyperhomocysteinemia in the developmentof preeclampsia is presented, which summarises our experiencein different biochemical and genetic points in relation to this possibleassociation. Plasma total homocysteine concentrations (tHcy) during pregnancywere significantly lower than those of non-pregnant women: 2nd trimester(median, 5.3 ìmol/l; range, 3.1-10.0 μmol/l); 3rd trimester(median, 6.3 μmol/l; range, 3.2-13.0 ìmol/l). Hyperhomocysteinemia(tHcy > P95) was established as values higher than 7.7 ìmol/l in the2nd trimester, and as values higher than 10.5 ìmol/l in the 3rd trimesterof pregnancy. We found an association between hyperhomocysteinemia and preeclampsia:tHcy values were significantly higher in the preeclampticgroup than in uncomplicated pregnancies; the OR for preeclampsia inhyperhomocysteinemic patients was 7.7 (CI 95%, 1.7-34.8). The otheramino acid concentrations were also higher in preeclamptic women.The negative correlation observed between homocysteine andfolate in the control group, was not present in preeclamptic women.
    Medicina Clínica 01/2003; 121(9):350-355. DOI:10.1157/13050826 · 1.25 Impact Factor